Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19
Condition(s):Corona Virus Infection; COVID-19Last Updated:July 2, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Corona Virus Infection; COVID-19Last Updated:July 2, 2020Unknown status
Condition(s):Kidney FailureLast Updated:October 22, 2012Completed
Condition(s):Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United KingdomLast Updated:November 13, 2020Unknown status
Condition(s):Congenital Heart DiseaseLast Updated:July 26, 2017Completed
Condition(s):COVID-19Last Updated:August 4, 2020Completed
Condition(s):Disorders Associated With Peritoneal DialysisLast Updated:April 11, 2012Completed
Condition(s):Cardiovascular Disease; Chronic Kidney DiseaseLast Updated:October 27, 2020Completed
Condition(s):SARS-CoV-2; COVID-19Last Updated:September 13, 2022Completed
Condition(s):COVID-19Last Updated:April 9, 2021Completed
Condition(s):Hypotension on InductionLast Updated:September 25, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.